UroGen Pharma
URGN
URGN
60 hedge funds and large institutions have $482M invested in UroGen Pharma in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2.03% more ownership
Funds ownership: 60.04% → 62.07% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
60
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$22.6M | |
| 2 | +$17M | |
| 3 | +$11.9M | |
| 4 |
BlackRock
New York
|
+$4.47M |
| 5 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$3.65M |
Top Sellers
| 1 | -$20M | |
| 2 | -$15.3M | |
| 3 | -$7.85M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.87M |
| 5 |
DP
DSAM Partners
London,
United Kingdom
|
-$3.32M |